3 ML testosterone undecanoate 250 MG/ML Injection
- RxCUI
- 1490661
- RxNorm name
- 3 ML testosterone undecanoate 250 MG/ML Injection
- Display name
- 3 ML testosterone undecanoate 250 MG/ML Injection
- Full name
- 3 ML testosterone undecanoate 250 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aveed | TESTOSTERONE UNDECANOATE | Endo USA, Inc. | f80f025b-17d8-40af-8739-20ce07902045 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 1490661 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f80f025b-17d8-40af-8739-20ce07902045 | 3 ML testosterone undecanoate 250 MG/ML Injection | SCD | 45 | These highlights do not include all the information needed to use AVEED ® safely and effectively. See full prescribing information for AVEED ® . AVEED ® (testosterone undecanoate) injection, for intramuscular use CIII Initial U.S. Approval: 1953 | 20250715 |
| f80f025b-17d8-40af-8739-20ce07902045 | testosterone undecanoate 750 MG per 3 ML Injection | SY | 45 | These highlights do not include all the information needed to use AVEED ® safely and effectively. See full prescribing information for AVEED ® . AVEED ® (testosterone undecanoate) injection, for intramuscular use CIII Initial U.S. Approval: 1953 | 20250715 |
| f80f025b-17d8-40af-8739-20ce07902045 | testosterone undecanoate 750 MG in 3 ML Injection | PSN | 45 | These highlights do not include all the information needed to use AVEED ® safely and effectively. See full prescribing information for AVEED ® . AVEED ® (testosterone undecanoate) injection, for intramuscular use CIII Initial U.S. Approval: 1953 | 20250715 |